sotorasib,docetaxel
amgen,sanofi,aventis
['sotorasib', 'lumakras', 'lung', 'docetaxel', 'amgen', '$amgn']
#amgen reported #lumakras #lumykras (#sotorasib) demonstrates superior progression-free survival over #docetaxel in first positive phase 3 trial of a #kras #g12c inhibitor in #nonsmallcelllungcancer #esmo22 $amgn 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.